The clinically important anaerobic, human pathogenic Bacteroides species and their antibiotic resistance levels in Central and Southeast Europe

1. Wexler HM. Bacteroides: the good, the bad and the nittygritty. Clin Microbiol Rev. 2007;20(4):593-621.10.1128/CMR.00008-07217604517934076Search in Google Scholar

2. Könönen E, Wade WG, Citron DM. Bacteroides, Porphyromonas, Prevotella, Fusobacterium, and other anaerobic Gram-negative rods. Manual of Clinical Microbiology, 10th Edition: American Society of Microbiology; 2011.10.1128/9781555816728.ch51Search in Google Scholar

3. Nagy E. Anaerobic infections: Update on treatment considerations. Drugs. 2010;70(7):841-58.10.2165/11534490-000000000-000002042649620426496Open DOISearch in Google Scholar

4. Sóki J. Extended role for insertion sequence elements in the antibiotic resistance of Bacteroides. World Journal of Clinical Infectious Diseases. 2013;3(1):1-12.10.5495/wjcid.v3.i1Open DOISearch in Google Scholar

5. Sóki J, Wareham DW, Rátkai C, Aduse-Opoku J, Urbán E, Nagy E. Prevalence, nucleotide sequence and expression studies of two proteins of a 5.6 kb, Class III, Bacteroides plasmid frequently found in clinical isolates from European countries. Plasmid. 2010;63(2):86-97.10.1016/j.plasmid.2009.12.00220026106Open DOISearch in Google Scholar

6. Rasmussen BA, Bush K, Tally FP. Antimicrobial resistance in Bacteroides. Clinical Infectious Diseases. 1993;16:S390-400.10.1093/clinids/16.Supplement_4.S3908324154Open DOISearch in Google Scholar

7. Clinical breakpoints [database on the Internet]. European Committee on Antimicrobial Susceptibility Testing (EUCAST). 2015-01. Available from: www.eucast.org/clinical:beakpoints/.Search in Google Scholar

8. Methods for antimicrobial susceptibility testing of anaerobic bacteria, Approved Standard, Document M11-A8 Clinical Laboratory Standards Institute, Wayne PA,; 2012.Search in Google Scholar

9. Nagy E, Justesen US, Eitel Z, Urbán E. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates. Anaerobe. 2015;31:65-71.10.1016/j.anaerobe.2014.10.00825464140Search in Google Scholar

10. Nagy E, Maier T, Urban E, Terhes G, Kostrzewa M. Species identification of clinical isolates of Bacteroides by matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry. Clinical Microbiology and Infection. 2009;15(8):796-802.10.1111/j.1469-0691.2009.02788.x19438622Search in Google Scholar

11. Nagy E, Becker S, Sóki J, Urbán E, Kostrzewa M. Differentiation of division I (cfiA-negative) and division II (cfiA-positive) Bacteroides fragilis strains by matrix-assisted laser desorption/ionization time of-flight mass spectrometry. Journal of Medical Microbiology. 2011;60(11):1584-90.10.1099/jmm.0.031336-021680764Search in Google Scholar

12. Johansson Å, Nagy E, Sóki J. Detection of carbapenemase activities of Bacteroides fragilis strains with matrix-assisted laser desorption ionization – Time of flight mass spectrometry (MALDI-TOF MS). Anaerobe. 2014;26:49-52.10.1016/j.anaerobe.2014.01.00624480431Search in Google Scholar

13. Snydman DR, Jacobus NV, McDermott LA, Ruthazer R, Golan Y, Goldstein EJC, et al. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997-2004. Antimicrobial Agents and Chemotherapy. 2007;51(5):1649-55.10.1128/AAC.01435-06185553217283189Search in Google Scholar

14. Snydman DR, Jacobus NV, McDermott LA, Golan Y, Goldstein EJC, Harrell L, et al. Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006–2009. Anaerobe. 2011;17(4):147-51.10.1016/j.anaerobe.2011.05.01421664469Search in Google Scholar

15. Snydman DR, Jacobus NV, McDermott LA, Golan Y, Hecht DW, Goldstein EJC, et al. Lessons learned from the anaerobe survey: Historical perspective and review of most recent data (2005-2007). Clinical Infectious Diseases. 2010;50(Suppl1):S26-33.10.1086/64794020067390Search in Google Scholar

16. Philips I, King A, Nord CE, Hoffstedt B on behalf of the ESCMID Study Group on Antimicrobial Resistance of Anaerobic Bacteria. Antibiotic sensitivity of Bacteroides fragilis group in Europe. European Journal of Clinical Microbiology & Infectious Diseases. 1992;11(4):292-304.10.1007/BF019620681396748Search in Google Scholar

17. Hedberg M, Nord CE on behalf of the ESCMID Study Group on Antimicrobial Resistance of Anaerobic Bacteria. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe. Clinical Microbiology and Infection. 2003;9(6):475-88.10.1046/j.1469-0691.2003.00674.x12848722Search in Google Scholar

18. Nagy E, Urbán E, Nord CE on behalf of the ESCMID Study Group on Antimicrobial Resistance of Anaerobic Bacteria. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe 20 years of experience. Clinical Microbiology and Infection. 2011;17(3):371-9.10.1111/j.1469-0691.2010.03256.x20456453Search in Google Scholar

19. Labbé A-C, Bourgault A-M, Vincelette J, Turgeon PL, Lamothe F. Trends in antimicrobial resistance among clinical isolates of the Bacteroides fragilis group from 1992 to 1997 in Montreal, Canada. Antimicrobial Agents and Chemotherapy. 1999;43(10):2517-9.10.1128/AAC.43.10.25178951110508035Search in Google Scholar

20. Wybo I, Van den Bossche D, Soetens O, Vekens E, Vandoorslaer K, Claeys G, et al. Fourth Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria. Journal of Antimicrobial Chemotherapy. 2014 January 1, 2014;69(1):155-61.10.1093/jac/dkt344Search in Google Scholar

21. Boyanova L, Kolarov R, Mitov I. Recent evolution of antibiotic resistance in the anaerobes as compared to previous decades. Anaerobe. 2015;31:4-10.10.1016/j.anaerobe.2014.05.00424875330Search in Google Scholar

22. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical Microbiology and Infection. 2012;18(3):268-81.10.1111/j.1469-0691.2011.03570.x21793988Open DOISearch in Google Scholar

23. Hartmeyer GN, Sóki J, Nagy E, Justesen US. Multidrugresistant Bacteroides fragilis group on the rise in Europe? Journal of medical microbiology. 2012 December 1, 2012;61(Pt 12):1784-8.10.1099/jmm.0.049825-0Search in Google Scholar

24. Katsandri A, Papaparaskevas J, Pantazatou A, Petrikkos GL, Thomopoulos G, Houhoula DP, et al. Two cases of infections due to multidrug-resistant Bacteroides fragilis group strains. Journal of Clinical Microbiology. 2006 September 1, 2006;44(9):3465-7.10.1128/JCM.00316-06Search in Google Scholar

25. Urbán E, Horváth Z, Sóki J, Lázár G. First Hungarian case of an infection caused by multidrug-resistant Bacteroides fragilis strain. Anaerobe. 2015;31(0):55-8.10.1016/j.anaerobe.2014.09.01925285854Search in Google Scholar

26. Cuchural G. J.; Tally FPJ, N. V.; Cleary, T.; Finegold, S. M.; Hill, G.; Iannini, P.; O’Keefe, P. O.; Pierson, C. Comparative activities od newer β-lactam agents against members of the Bacteroides fragilis group. Antimicrobial Agents and Chemotherapy. 1990;34(3):479-80.10.1128/AAC.34.3.4791716202334161Open DOISearch in Google Scholar

27. Snydman DR, Jacobus NV, McDermott LA. Evaluation of the in vitro activities of doripenem, a new broad spectrum carbapenem, against recent clinical anaerobic isolates with emphasis on the Bacteroides fragilis group. Antimicrobial Agents and Chemotherapy. 2008(Journal Article).10.1128/AAC.00696-08259288518838581Search in Google Scholar

28. Marina M, Ivanova M, Kantardjiev T. Antimicrobial susceptibility of anaerobic bacteria in Bulgaria. Anaerobe. 2009;15(4):127-32.10.1016/j.anaerobe.2009.03.00219292999Search in Google Scholar

29. Nagy E, Szőke I, Gacs M, Csiszár K. Antibiotic susceptibility of Bacteroides fragilis group strains in Hungary. Anaerobe. 1995 1995/10/01;1(5):269-74.10.1006/anae.1995.102616887535Search in Google Scholar

30. Papaparaskevas J, Pantazatou A, Katsandri A, Legakis NJ, Avlamis A. Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece. Clinical Microbiology and Infection. 2005;11(10):820-4.10.1111/j.1469-0691.2005.01233.x16153256Search in Google Scholar

31. Papaparaskevas J, Pantazatou A, Katsandri A, Houhoula DP, Legakis NJ, Tsakris A, et al. Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in Greece. Journal of Antimicrobial Chemotherapy. 2008;62(1):137-41.10.1016/j.ijantimicag.2007.10.003Open DOISearch in Google Scholar

32. Grisold AJ, Wendelin I, Presterl E, Raggam RB, Masoud L, Badura A, et al. In vitro activity of ten antibiotics, including tigecycline, against Bacteroides species in Austria. European Journal of Clinical Microbiology & Infectious Diseases. [journal article]. 2007;26(7):525-7.10.1007/s10096-007-0318-017562088Open DOISearch in Google Scholar

33. Novak A, Rubic Z, Dogas V, Goic-Barisic I, Radic M, Tonkic M. Antimicrobial susceptibility of clinically isolated anaerobic bacteria in a University Hospital Centre Split, Croatia in 2013. Anaerobe. 2015;31:31-6.10.1016/j.anaerobe.2014.10.01025479237Search in Google Scholar

34. Székely E, Eitel Z, Molnár S, Szász IÉ, Bilca D, Sóki J. Analysis of Romanian Bacteroides isolates for antibiotic resistance levels and the corresponding antibiotic resistance genes. Anaerobe. 2015;31:11-4.10.1016/j.anaerobe.2014.09.00125218409Search in Google Scholar

35. Kierzkowska M, Majewska A, Sawicka-Grzelak A, Mlynarczyk A, Chmura A, Kwiatkowski A, et al. Antibiotic resistance profiles of strictly anaerobic Gram-negative Bacteroides spp. and Parabacteroides spp. bacilli isolated from infected inpatients on surgical wards. Journal of Global Antimicrobial Resistance. 2016;7:128-9.10.1016/j.jgar.2016.09.00127770692Search in Google Scholar

36. Jeverica S, Kolenc U, Mueller-Premru M, Papst L. Evaluation of the routine antimicrobial susceptibility testing results of clinically significant anaerobic bacteria in a Slovenian tertiary-care hospital in 2015. Anaerobe. 2017;47:64-9.10.1016/j.anaerobe.2017.04.00728433670Search in Google Scholar